Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Other
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Preclinical/no trial
- ChEMBL max phase
- 3 / 4 (development scale, not regulatory approval)
- Synonyms
- Uridine; Uracil riboside; 1-beta-d-ribofuranosyluracil; NSC-20256
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatOtherWistarMalen = Six rats per group, four groupsIntravenous0.3 mg per 100 g body weight; the mitochondrial ATP-depende…Uridine 30 min before hypoxic exposure; 5-hydroxydecanoate 10 min after uridine…
Model: Acute hypoxic hypoxia produced by 30 min exposure to a gas mixture of 7% oxygen in nitrogen in a sealed 10 L chamber
Hypoxia thickened all layers of the air-blood barrier (epithelial by 61%, interstitial by 47%, endothelial 2.3-fold on arithmetic thickness), raised total mitochondrial number by 88.4% and increased structurally damaged mitochondria sevenfold. Uridine returned epithelial thickness to control values…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.